ONYX PHARMACEUTICALS INC Operating Expenses
ONYX PHARMACEUTICALS INC reported Operating Expenses of $200.56 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC operating expenses for the quarter ending 2013-06-30 was $200.56M, a 12.37% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating expenses for the quarter ending 2013-03-31 was $173.97M, a 41.69% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating expenses for the quarter ending 2012-12-31 was $166.13M, a 978.89% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating expenses for the quarter ending 2012-09-30 was $161.86M, a 50.92% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating expenses for fiscal 2012 was $629.25M, a 80.37% increase from fiscal 2011.
- ONYX PHARMACEUTICALS INC operating expenses for fiscal 2011 was $348.87M, a 11.19% decline from fiscal 2010.
- ONYX PHARMACEUTICALS INC operating expenses for fiscal 2010 was $392.84M, a 69.94% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC operating expenses for fiscal 2009 was $231.17M, a 12.91% increase from fiscal 2008.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2013-06-30 | $200.56M 10-Q · filed 2013-08-09 | $374.52M 10-Q · filed 2013-08-09 | $540.65M derived: sum of 3 quarters · filed 2013-08-09 | $702.51M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $173.97M 10-Q · filed 2013-05-08 | $340.09M derived: sum of 2 quarters · filed 2013-05-08 | $501.96M derived: sum of 3 quarters · filed 2013-05-08 | $680.43M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $166.13M 10-K · filed 2013-02-28 | $327.99M derived: sum of 2 quarters · filed 2013-02-28 | $506.47M derived: sum of 3 quarters · filed 2013-08-09 | $629.25M 10-K · filed 2013-02-28 |
| 2012-09-30 | $161.86M 10-K · filed 2013-02-28 | $340.34M derived: sum of 2 quarters · filed 2013-08-09 | $463.12M 10-Q · filed 2012-11-02 | $478.52M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $178.48M 10-Q · filed 2013-08-09 | $301.26M 10-Q · filed 2013-08-09 | $316.66M derived: sum of 3 quarters · filed 2013-08-09 | $423.91M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $122.78M 10-Q · filed 2013-05-08 | $138.18M derived: sum of 2 quarters · filed 2013-05-08 | $245.43M derived: sum of 3 quarters · filed 2013-05-08 | $363.19M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $15.40M 10-K · filed 2013-02-28 | $122.65M derived: sum of 2 quarters · filed 2013-02-28 | $240.41M derived: sum of 3 quarters · filed 2013-02-28 | $348.87M 10-K · filed 2013-02-28 |
| 2011-09-30 | $107.25M 10-K · filed 2013-02-28 | $225.01M derived: sum of 2 quarters · filed 2013-02-28 | $333.47M 10-Q · filed 2012-11-02 | $416.51M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $117.76M 10-K · filed 2013-02-28 | $226.22M 10-Q · filed 2012-08-06 | $309.27M derived: sum of 3 quarters · filed 2013-02-28 | $385.38M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $108.46M 10-K · filed 2013-02-28 | $191.50M derived: sum of 2 quarters · filed 2013-02-28 | $267.62M derived: sum of 3 quarters · filed 2013-02-28 | $429.55M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $83.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $159.16M derived: sum of 2 quarters · filed 2013-02-28 | $321.09M derived: sum of 3 quarters · filed 2013-02-28 | $392.84M 10-K · filed 2013-02-28 |
| 2010-09-30 | $76.11M 10-Q · filed 2011-11-03 | $238.05M derived: sum of 2 quarters · filed 2011-11-03 | $309.79M 10-Q · filed 2011-11-03 | $379.58M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $161.94M 10-Q · filed 2011-08-09 | $233.68M 10-Q · filed 2011-08-09 | $303.47M derived: sum of 3 quarters · filed 2012-02-27 | $362.54M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $71.74M 10-Q · filed 2011-05-10 | $141.53M derived: sum of 2 quarters · filed 2012-02-27 | $200.61M derived: sum of 3 quarters · filed 2012-02-27 | $252.14M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $69.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $128.86M derived: sum of 2 quarters · filed 2012-02-27 | $180.39M derived: sum of 3 quarters · filed 2012-02-27 | $231.17M 10-K · filed 2012-02-27 |
| 2009-09-30 | $59.08M 10-Q · filed 2010-11-03 | $110.60M derived: sum of 2 quarters · filed 2010-11-03 | $161.38M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $51.53M 10-Q · filed 2010-08-04 | $102.30M 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | $204.74M 10-K · filed 2011-02-23 |